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Abstract
The Global Alliance for Infections in Surgery appreciates the great effort of the task force who derived and validated
the Sepsis-3 definitions and considers the new definitions an important step forward in the evolution of our
understanding of sepsis. Nevertheless, more than a year after their publication, we have a few concerns regarding
the use of the Sepsis-3 definitions.
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Background
The definition of sepsis has shifted over time.
Systemic inflammatory response syndrome (SIRS), sepsis,
severe sepsis, and septic shock were initially defined in
1991 by a consensus panel convened by the American
College of Chest Physicians (ACCP) and the Society of
Critical Care Medicine (SCCM) [1]. The conference defined
sepsis as a systemic inflammatory response syndrome
(SIRS) due to infection. “Severe” sepsis was defined as
sepsis associated with organ dysfunction, hypoperfusion, or
hypotension, and “septic shock” was defined as sepsis with
arterial hypotension despite adequate fluid resuscitation
(Appendix 1).
The definitions were revisited in 2001 during the
International Sepsis Definitions Conference, which
included members from the ACCP, the SCCM, the
American Thoracic Society (ATS), the European Society
of Intensive Care Medicine (ESICM), and the Surgical
Infection Society (SIS). [2] The consensus retained the
definitions of sepsis as SIRS due to infection (presumed
or confirmed) and severe sepsis as sepsis associated with
acute organ dysfunction. However, the new criteria
defining SIRS were greatly expanded from the 1991
original, and organ dysfunction variables indicative of
severe sepsis were also defined. This new set of sepsis
criteria also changed the diagnostic requirement from
“more than 1” of the original 4 to “some” of the
expanded list (Appendix 2).* Correspondence: massimosartelli@gmail.com
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In February 2016, the Journal of the American
Medical Association (JAMA) published a proposal for
new definitions and criteria for sepsis, called Sepsis-3
[3], updating previous sepsis definitions [1, 2]. The new
definitions were prepared by a task force appointed by
the European Society of Intensive Care Medicine
(ESICM) and the Society of Critical Care Medicine
(SCCM) (Appendix 3). They were aimed at providing a
standardized classification to facilitate clinical care,
future research, and reporting.
In 2017, the Global Alliance for Infections in Surgery
instituted an interdisciplinary task force of 76 experts
from 50 different countries with different backgrounds
to assess the clinical value of the Sepsis-3 definitions.
The Global Alliance for Infections in Surgery appreciates
the great effort of the task force who derived and validated
the Sepsis-3 definitions and considers the new definitions
an important step forward in the evolution of our under-
standing of sepsis particularly in regard to what distin-
guishes sepsis from uncomplicated infection. Nevertheless,
more than a year after their publication, we have a few
concerns regarding the use of the Sepsis-3 definitions [3].
We hope our comments can encourage further discussion
and debate on how to further optimize the definitions of
the sepsis continuum.
Sepsis-3 definitions
The process for revising the Sepsis-3 definitions of sepsis
and septic shock was a 2-year-long process that involved
several components [3]. Critical efforts in this process in-
cluded a discussion of the concept of sepsis, identification
of criteria alerting clinicians for the patient’s risk to
develop sepsis, and the development of the criteria to
identify septic shock.
The clinical criteria for sepsis were formulated by using a
data-driven approach. Electronic health record data of 1.3
million encounters at 12 community and academic hospi-
tals within the University of Pittsburgh Medical Center
health system in southwestern Pennsylvania were studied,
and among them, there were 148,907 patients with
suspected infection. The power of the Sequential
[sepsis-related] Organ Failure Assessment (SOFA) was
equivalent to Logistic Organ Dysfunction Score (LODS)
and higher than SIRS in predicting hospital mortality in
the intensive care unit (ICU). The choice of the SOFA to
measure organ dysfunction was due to its greater simpli-
city. The task force introduced the rapid bedside quick
SOFA (qSOFA) tool for determined patients outside the
ICU who likely develop sepsis from the retrospectively
derived databases. Confirmatory analyses were performed
by using data sets from the USA and Germany.
The clinical criteria for septic shock were formu-
lated by using multiple methods: (a) a systematic
literature review and meta-analysis of the criteria used
in observational studies reporting sepsis epidemiology,
(b) a Delphi process among the 19 members of the task
force to achieve consensus on the new definitions, and (c)
cohort studies to test variables identified by the Delphi
process using the Surviving Sepsis Campaign registry,
along with two other data sets from the USA.
Yet when they were published, these definitions, however,
had not been prospectively validated in a generalizable
population. Moreover, the patient data were all almost
exclusively from adults in high-income countries and
primarily contained information from patients in the USA
and Germany, so the utility of these definitions in other
geographic regions and particularly in settings with less
resources is unknown.
In recent years, the SIRS criteria were criticized for
being too non-specific. The current use of two or more
SIRS criteria to identify sepsis was unanimously
considered by the task force to be unhelpful.
However, the task force stated that, although SIRS
was not helpful in identifying patients with organ
dysfunction, non-specific SIRS criteria still might have
utility in identifying patients having infection.
Sepsis is now defined as life-threatening organ
dysfunction caused by a dysregulated host response to
infection. The aim of this definition is to emphasize the
primacy of the non-homeostatic host response to infec-
tion, the potential lethality, and the need for urgent
recognition.
Organ dysfunction can be represented by an increase in
the Sequential [sepsis-related] Organ Failure Assessment
(SOFA) score of 2 points or more (Table 1) which is asso-
ciated with an in-hospital mortality greater than 10%.
Septic shock is defined as a subset of sepsis and should
be clinically identified by a vasopressor requirement to
maintain a mean arterial pressure of 65 mmHg or greater
and serum lactate level greater than 2 mmol/l (> 18 mg/
dl) in the absence of hypovolemia. The term “severe
sepsis” is now superfluous and has been removed from
the current definitions.
The Sepsis-3 definitions suggest that patients with
at least two of these three clinical variables may be
prone for the poor outcome typical of sepsis: (1) low
blood pressure (SBP ≤ 100 mmHg), (2) high respira-
tory rate (≥ 22 breaths per min), or (3) altered menta-
tion (Glasgow coma scale < 15) (quick SOFA). It is
supposed to be useful in out-of-hospital, emergency
surgery (ED), or general hospital ward settings, and
patients with positive qSOFA should be used to
further investigate for organ dysfuntion. The qSOFA
score should not be regarded as a diagnostic criterion
for defining sepsis. Rather, it should be regarded as a
warning for patients with suspected infection who are
likely to have poor outcomes.
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Raising concerns about the Sepsis-3 definitions
Sepsis is a multifaceted host response to an infecting
pathogen that may be significantly amplified by
endogenous factors. If left untreated, it may lead to the
functional impairment of one or more vital organs or
systems [4].There are many well-known risk factors for
the infections that most commonly precipitate organ
dysfunction, including acquired immunodeficiency syn-
drome, chronic obstructive pulmonary disease, many
cancers, the use of immunosuppressive agents, and
advanced age [5]. Although big steps forward have
been made, the pathophysiological mechanisms for
organ dysfunction are not entirely known, but it has
become apparent that infection triggers a much more
complex, variable, and prolonged host response, involving
early activation of both pro- and anti-inflammatory
responses.
Sepsis has variable clinical presentations depending on
the initial site of infection, the causative organism, the
pattern of acute organ dysfunction, and the underlying
health status of the patient [5].
There is general consensus that early recognition and
timely treatment largely determine outcome of sepsis.
Since the first classification in 1991 [1], the definition
of sepsis, severe sepsis, and septic shock, though impre-
cise, have provided the clinicians a useful framework for
clinical management, stressing the need for early recog-
nition [6], and when these criteria are followed by the
application of the Surviving Sepsis Campaign recom-
mendations, they have an impressive history of success
in reducing the mortality of sepsis in several areas of the
world [7].
Several studies demonstrated that sepsis-related mortality
reduced steadily over the years. A meta-analysis reported a
reduction of sepsis 28-day mortality rates from 46.9%
during the period 1991–1995 to 29% during 2006–2009 [8].
In the USA, mortality due to severe sepsis decreased by
51% from 1988 to 2012 [9]. In Australia and New Zealand,
an overall decrease of 16.7% in hospital sepsis mortality was
reported between 2000 and 2012 (from 35 to 18.4%) [10].
However, high mortality rates are still reported in low- and
middle-income countries [11].
Despite decades of sepsis research, no specific therapies
for sepsis have emerged. Without specific therapies,
management is based on control of the infection and
organ support.
Early antibiotics, source control, and fluid resuscitation
support of vital organ function are the cornerstones for
the treatment of patients with sepsis [12].
Timing and adequacy of source control are the most
important issues in the management of patients with
complicated intra-abdominal infections (cIAIs) because
inadequate and late operation may have a negative effect
on outcome. Source control was considered an essential
element in the management of patients with complicated
intra-abdominal infections (cIAIs) and should be
considered and performed early after the diagnosis is
established in most if not all patients [13]. Sotto et al. in
2002 found in a retrospective study that time between
diagnosis and operation was associated with mortality
[14]. In this study, the period between diagnosis and
surgery was predictive of death within 30 days after
diagnosis of peritonitis, emphasizing the importance of
prompt surgical treatment. In the CIAOW (complicated
intra-abdominal infections worldwide) observational
study including 1898 consecutive patients older than
18 years undergoing surgery or interventional drainage
to address IAI, a delayed initial intervention was found
Table 1 SOFA score
PaO2/FiO2 (mmHg) SOFA
score
< 400 1
< 300 2
< 200 and mechanically ventilated 3
< 100 and mechanically ventilated 4
Glasgow coma scale
13–14 1
10–12 2
6–9 3
< 6 4
Mean arterial pressure OR administration of vasopressors
required
SOFA
score
MAP < 70 mm/Hg 1
dop ≤ 5 or dob (any dose) 2
dop > 5 OR epi ≤ 0.1 OR nor ≤ 0.1 3
dop > 15 OR epi > 0.1 OR nor > 0.1 4
Bilirubin (mg/dl) [μmol/l]
1.2–1.9 [> 20–32] 1
2.0–5.9 [33–101] 2
6.0–11.9 [102–204] 3
> 12.0 [> 204] 4
Platelets ×103/μl
< 150 1
< 100 2
< 50 3
< 20 4
Creatinine (mg/dl) [μmol/l] (or urine output)
1.2–1.9 [110–170] 1
2.0–3.4 [171–299] 2
3.5–4.9 [300–440] (or < 500 ml/d) 3
> 5.0 [> 440] (or < 200 ml/d) 4
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to be an independent variable predictive of mortality. In
this study, the overall mortality rate was 10.5% (199/
1898) [15].
To enable early interventions being effective, the
diagnosis must be made as early as possible and
treatment must be started early. The ability to identify
septic patients who are at high risk for subsequent organ
dysfunction and mortality, starting from pre-hospital
care and ED, is crucial since timely recognition and
appropriate, effective treatment substantially improves
survival. This highlights the need for all healthcare
workers to be vigilant about sepsis, so that the diagnosis
can be made as early as possible [16].
One consequence of the new definitions is elimination
of the concept of sepsis without organ dysfunction.
Although the task force considered that the new defini-
tions may better reflect the current understanding of
sepsis pathophysiology, the literal interpretation of
“sepsis” as a problem only when life-threatening organ
dysfunction appears may be of limited utility in identifying
patients who may benefit from early intervention.
The Sepsis-3 definitions requiring the presence of organ
dysfunction to define sepsis may hinder the awareness of
the importance of early recognition and treatment of in-
fections before organ dysfunction appears, de-emphasizing
intervention at earlier stages when it is most treatable.
Ideally, patients at risk for sepsis should be identified
before organ dysfunction is established. Therefore, it
may be questionable if it is helpful to have a definition
that recognizes a patient once organ dysfunction has
occurred and the patient already needs intensive care.
An observational study conducted at 132 medical
institutions worldwide over a 4-month study period
enrolled 4533 patients to validate a predictive score for
patients with intra-abdominal infections [17]. Data from
the WSES cIAIs Score Study (WISS) showed that mor-
tality was significantly affected by the previous sepsis
definition. Mortality with no sepsis was 1.2%, with sepsis
only 4.4%, with severe sepsis 27.8%, and with septic
shock was 67.8%. Severity of illness and the inherent
mortality risk escalated from no sepsis, through sepsis,
severe sepsis, and septic shock.
The previous stratification of the severity and conse-
quent mortality due to infection that progressed from no
sepsis to sepsis (infection meeting the criteria for systemic
inflammatory response syndrome or SIRS), to severe sepsis
(sepsis with organ failure, arterial hypertension, and/or hy-
poperfusion), to septic shock (arterial hypotension
refractory to adequate volume resuscitation) is now
reduced to simple infection, sepsis (infection and organ
dysfunction), and septic shock (arterial hypotension de-
fined as the use of vasopressors and hyperlactatemia). The
previous concept of severe sepsis corresponds now to the
definition of sepsis in the Sepsis-3 criteria, although this
correlation is not absolute because sepsis, according to the
new criteria, can include very different conditions, such as
organ failure without hypotension nor hyperlactatemia [7].
The Sepsis-3 definitions exclude patients with isolated
hypotension from the definition of sepsis because they
would have a SOFA score of 1. Moreover, lactate is not
part of the SOFA score, even though it is well documented
to be a sensitive marker of severity of illness in patients
with infection.
The Sepsis-3 definitions recommend using an increase
in the SOFA score of 2 or more points to represent
organ dysfunction. The SOFA score is intended to be
used in the ICU and, to a lesser extent, the ED. Outside
the ICU, SOFA was found only as good as the previous
SIRS criteria (AUROC = 0.79 vs. AUROC = 0.76).
Moreover, it is a valuable predictor of unfavorable out-
come. The SOFA score was proposed in 1996 by the
Working Group on Sepsis-Related Problems of the
European Society of Intensive Care Medicine [18] to ob-
jectively describe the degree of organ dysfunction over
time and to evaluate morbidity in patients in the ICU
with sepsis. It was demonstrated to be a good indicator
of prognosis in critically ill patients during the first few
days of ICU admission [19]. The use of the SOFA score
in research is commonly performed and constitutes a
routine component of data collection for clinical trials in
ICUs. However, the SOFA score is not universally
accessible, especially for PaO2, which would require an
arterial blood gas measurement.
Recognizing these practical limitations, the task force
described a simplified method termed the “quick SOFA”
(qSOFA) score to facilitate easier identification of
patients potentially at risk of dying outside of critical
care settings [20]. This instrument, which had not been
validated in clinical practice at the time of Sepsis-3
publication, comprises three clinical parameters that are
easy to assess outside the ICU.
The prognostic accuracy for in-hospital mortality of
qSOFA is an area of great debate. A recent multicenter
prospective cohort study involving 879 patients with sus-
pected infection treated in the ED reported that qSOFA
may be better than previous criteria at predicting in-
hospital mortality among patients with suspected infection
[21]. Nevertheless, we calculated the positive predictive
value (PPV) of qSOFA for in-hospital death in this study
to be only 0.24. This indicates that only one-quarter of the
patients who had a qSOFA equal or more than 2 died in
the hospital.
A recent large retrospective cohort analysis of 184,875
patients in 182 Australian and New Zealand intensive
care units (ICUs) found that SOFA score had superiority
in prediction of in-hospital mortality and that SIRS
criteria had a greater prognostic accuracy for in-hospital
mortality than qSOFA score [22].
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In an observational cohort study performed at one ED
at an urban university teaching hospital in Norway [23],
qSOFA failed to identify two thirds of the patients
admitted to an ED with severe sepsis. Further, qSOFA
failed to be a risk stratification tool as the sensitivity to
predict 7-day and 30-day mortality was low. The
sensitivity was poorer than the other warning scores
already in use at the study site and the SIRS criteria.
In a study of 886 patients, Tusgul et al. showed that the
qSOFA score, SIRS criteria, and sepsis definition have low
identification sensitivity in selecting septic patients in the
pre-hospital setting or upon arrival in the ED [24].
An important limitation of the new definitions is the
poor sensitivity of the qSOFA scoring system. This leads
to a high number of false negatives and, subsequently, to
a delayed diagnosis in many patients, which likely ex-
cludes its use as a screening tool for early sepsis, the
stage in which treatment is most effective.
In a recent analysis of three prospectively collected,
observational cohorts of 7754 infected emergency
department patients aged 18 years or older, Henning et
al. [25] demonstrated that the mortality rate for patients
with a qSOFA score greater than or equal to 2 was
14.2%, with a sensitivity of 52% and specificity of 86% to
predict mortality. In comparison, the original SIRS-based
Sepsis-2 definition had a mortality rate of 6.8%, a sensitiv-
ity of 83%, and a specificity of 50%. Both the Sepsis-2 and
Sepsis-3 definitions stratified patients at risk for mortality,
with differing performances. In terms of mortality predic-
tion, the new definitions had improved specificity but had
very low sensitivity.
Williams et al. prospectively studied 8871 consecutive
patients who were admitted from the ED with presumed
infection and compared the diagnostic accuracy of SIRS
with qSOFA and Sepsis-2 with Sepsis-3 definitions for
organ dysfunction [26]. SIRS was associated with
increased risk of organ dysfunction and mortality in
patients without organ dysfunction. SIRS and qSOFA
showed similar discrimination for organ dysfunction.
qSOFA was specific but poorly sensitive for organ
dysfunction. Mortality for patients with organ dysfunction
was similar for Sepsis-2 and Sepsis-3, although 29% of
patients with Sepsis-3 organ dysfunction did not meet
Sepsis-2 criteria. Increasing numbers of Sepsis-2 organ
system dysfunctions were associated with greater
mortality.
In another study in which 3346 patients with infection
outside the ICU and 1058 patients with infection in the
ICU were analyzed, qSOFA provided inadequate sensitivity
for early risk assessment [27].
Peake et al. performed a post hoc analysis of 1591
adult patients presenting to the ED with early septic
shock [28]. At baseline, 1139 patients had a qSOFA
score of ≥ 2. In contrast, 1347 participants met the
Sepsis-3 criteria for sepsis. Of these, 1010 participants
had a qSOFA score of ≥ 2 and met the Sepsis-3 criteria
for sepsis. A quarter of participants who met the new
sepsis definitions did not fulfill the qSOFA screening
criteria, potentially limiting its utility as a screening tool
for sepsis in the ED.
Sepsis requires urgent recognition because delayed
treatment increases mortality. To optimize the timing of
therapy, a screening test should be as sensitive as
possible. Thus, it is preferable to have a more sensitive
test with lower false negative results in order to not miss
cases of serious sepsis.
Although some patients with ongoing sepsis may not have
elevated lactate levels at presentation or during their clinical
course [29], lactate measurement is advised as an important
component of the initial evaluation of patients with sepsis.
Elevated lactate levels (even if > 4 mmol/l) are no longer part
of organ dysfunction criteria to define organ failure.
In the new definition of septic shock, hyperlactatemia is
a required component for septic shock, differently from
Sepsis-1 and Sepsis-2 definitions in which just the presence
of refractory hypotension to fluid loading was considered
shock. Therefore, when lactate measurements are not
available, the diagnosis of septic shock can be more
challenging and patients with potential shock will be
considered as having only sepsis.
Discussion
Sepsis was previously defined as a systemic inflammatory
response syndrome (SIRS) in a patient with an infection
but now reflects a significantly greater degree of illness,
characterized by organ dysfunction, de-emphasizing
intervention at earlier stages when it is most treatable.
Definition of organ failure based on SOFA ≥ 2 may be
accurate and safe in the ICU, although reliance on the
SOFA score can make it more challenging to diagnose a
patient with sepsis outside the ICU environment.
The SOFA score is not globally accessible and not well
known by emergency or ward healthcare professionals,
and its applicability is complex outside the ICU, as it
might demand the calculation of SOFA for subsequent
days to verify if the patients fulfill the strict criteria and
require laboratory tests [30].
The qSOFA is a tool for risk stratification, and it seems
necessary to look for options to improve its low sensitivity.
Until then, SIRS will still be helpful as a screening tool in
ED to identify patients with infections that will most likely
benefit from earlier and more aggressive interventions.
Clinicians should keep in mind the difference between a
screening tool and a risk-stratification tool. A screening
tool aims to identify patients with a particular disease
from a larger pool of patients. Once these patients are
identified, a risk-stratification tool can be applied to deter-
mine their likelihood of meeting a particular outcome.
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We probably still need a good screening tool to identify
patients at risk of developing organ dysfunction. However,
this is not addressed in Sepsis-3.
The Sepsis-3 authors concluded that “These updated
definitions and clinical criteria should clarify long-used
descriptors and facilitate earlier recognition and more
timely management of patients with sepsis or at risk of
developing it.” However, it seems to us that Sepsis3
definitions have the opposite outcome.
Sepsis 3 definitions exclude from the concept of sepsis
those patients who are in transition from infection to
sepsis and who have a SOFA score of 2 or more points.
Probably, a pre-sepsis scoring concept is missing [31]
and should be mandatory.
Fever, tachypnea, tachycardia, and increased WBC count
are consistent features of critical illnesses, including those
induced by infection. Although the SIRS criteria have been
criticized for their lack of specificity, since 1991, they have
gained widespread acceptance among clinicians all over the
world and are still used worldwide to recognize early sepsis
in clinical practice.
Instead of replacing the SIRS score with the new
qSOFA score to identify early patients with sepsis, why
not use both of them together, taking advantage of the
sensitivity of SIRS and the specificity of qSOFA?
The new definitions are based on a retrospective
evaluation of large hospital databases from two countries
(the USA and Germany).The majority of sources of
infection were hospital patients in referral centers with
respiratory and postoperative infections. The target reader
is an intensive care unit (ICU) physician. Although these
definitions are of help for research purposes, they may not
be representative of the wider clinical community [32].
Major international differences exist in the prevalence of
infections, types of infecting microorganisms, and mortal-
ity rates. EPIC II demonstrated significant differences in
Eastern Europe as compared to Western Europe, in
Australasia as compared to Asia, and in Latin America as
compared to North America [33].
Early recognition of sepsis is a general principle of sepsis
management and is very important in low- and middle-in-
come countries where the priorities for improving the qual-
ity of care for critically ill patients are different.
Documenting the burden of critical illness in low-resource
settings is challenging [29]. In these settings, a triage system
that quickly recognizes critically ill patients and transfers
them immediately to an acute care unit is a vital compo-
nent of the emergency services. The most important chal-
lenges in the management of sepsis in these areas are triage
and pre-hospital diagnosis. It should be done by very sensi-
tive and non-invasive methods outside the hospital setting.
As a consequence, any process of improving quality
of sepsis care globally should focus on simple diag-
nostic criteria based on physical examination findings
that can recognize patients needing critical care. In
these settings, a feasible, low-cost method of rapidly iden-
tifying patients requiring critical care is crucial. Early
warning system scores utilize physiological, easy-to-
measure parameters, assessing physiological parameters
such as systolic blood pressure, pulse rate, respiratory rate,
temperature, oxygen saturations, and level of conscious-
ness [34]. They are simple, non-invasive, and easy-to-
repeat measurement bedside tools. Large multicenter
trials will be needed to explore if these findings can be
shared all over the world.
Conclusions
The pathogenesis of sepsis involves a complex interaction
between the host immune system and the infecting
microorganisms. Sepsis describes a broad-based syndrome
covering many infectious agents, affecting various sites in
patients of differing age, gender, and comorbidity. Its
clinical manifestations are highly variable and may lead to
severe organ dysfunction and death. Despite remarkable
advances in the management of patients with sepsis, its
recognition and timely, appropriate treatment remain of
utmost importance.
The Sepsis-3 definitions underline the concept of a
dysregulated immune response resulting in potentially
modifiable life-threatening organ dysfunction. However,
they may fail in identifying patients with serious infections
before organ dysfunction ensues.
Downplaying infections that do not meet the current
Sepsis-3 criteria may hinder their identification, resulting in
an unnecessary increase in both morbidity and mortality
due to their inexorable progression in the following hours.
Clear definitions for sepsis and septic shock should
guide clinicians both to support early recognition of
at-risk patients and to facilitate an understanding of the
global epidemiology of sepsis.
Sepsis is a burden for global health. Its global nature
calls for a global response, both in the geographic sense
and across the whole range of sectors involved.
In this paper, we have raised our concerns regarding
the Sepsis-3 definitions. We believe that in order for
sepsis definitions to be universally accepted, they should
facilitate clinical care on a global scale.
On Friday, May 26th, 2017, the World Health Assembly
and the World Health Organization made sepsis a global
health priority, by adopting a resolution to improve,
prevent, diagnose, and manage sepsis [35].
The Global Alliance for Infections in Surgery suggests
that future revisions have a more global perspective and
include a wider range of representatives and expertise.
We also hope our comments can serve as a basis for fu-
ture discussions on how to further improve the
definitions of the sepsis continuum.
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Appendix 1
Sepsis-1 definitions
SIRS (systemic inflammatory response syndrome)
Presence of more than 1 of 4 findings:
 Body temperature > 38.0 or < 36.0 °C
 Heart rate > 90 beats/min
 Tachypnea > 20 breaths/min or hyperventilation
with PaCO2 < 32 mmHg
 White blood cell (WBC) count > 12,000 cells/mm3
or < 4000 cells/mm3
Sepsis
SIRS in the presence of a confirmed or suspected
infection.
Severe sepsis
Sepsis associated with organ dysfunction, hypoperfusion,
or hypotension,
Septic shock
Sepsis with arterial hypotension despite adequate fluid
resuscitation.
Appendix 2
Sepsis-2 definitions
Sepsis
Infection documented or suspected and some of the
following parameters:
General parameters
 Fever (core temperature > 38.3 °C)
 Hypothermia (core temperature < 36 °C)
 Heart rate 90 bpm or > 2 SD above the normal value
for age
 Tachypnea: > 30 bpm
 Altered mental status, significant edema or positive
fluid balance (> 20 ml/kg over 24 h)
 Hyperglycemia (plasma glucose > 110 mg/dl or
7.7 mM/l) in the absence of diabetes
Inflammatory parameters
 Leukocytosis (white blood cell count > 12,000/μl)
 Leukopenia (white blood cell count < 4000/μl)
 Normal white blood cell count > 10% immature
forms
 Plasma C reactive protein > 2 SD above the normal
value
 Plasma procalcitonin > 2 SD above the normal value
Hemodynamic parameters
 Arterial hypotension (systolic blood pressure < 9
0 mmHg, mean arterial pressure < 70)
 Or a systolic blood pressure decrease > 40 mmHg in
adults or < 2 SD below normal for age
 Mixed venous oxygen saturation > 70%
 Cardiac index > 3.5 l min− 1 m− 2
 Organ dysfunction parameters
 Arterial hypoxemia (PaO2/FIO2 < 300)
 Acute oliguria (urine output > 0.5 ml/kg− 1 h− 1 or
45 mM/l for at least 2 h)
 Creatinine increase ≥ 0.5 mg/dl
 Coagulation abnormalities (international normalized
ratio > 1.5 or activated partial thromboplastin time >
60 s)
 Ileus (absent bowel sounds)
 Thrombocytopenia (platelet count 4 mg/dl or
70 mmol/l)
Tissue perfusion parameters
 Hyperlactatemia (> 3 mmol/l)
 Decreased capillary refill or mottling
Appendix 3
Sepsis-3 definitions
Sepsis
Life-threatening organ dysfunction due to a dysregulated
host response to infection.
Sepsis clinical criteria: organ dysfunction is defined as
an increase of 2 points or more in the Sequential Organ
Failure Assessment (SOFA) score.
Patients with suspected infection who are likely to
have a prolonged ICU stay or to die in the hospital can
be promptly identified at the bedside with qSOFA. Two
or more of:
 Hypotension: SBP less than or equal to 100 mmHg
 Altered mental status (any GCS less than 15)
 Tachypnoea: RR greater than or equal to 22
Septic shock
Subset of sepsis in which underlying circulatory and
cellular/metabolic abnormalities are profound enough to
substantially increase mortality.
Septic shock clinical criteria: Sepsis and (despite
adequate volume resuscitation) both of:
Persistent hypotension requiring vasopressors to maintain
MAP greater than or equal to 65 mmHg, and lactate greater
than or equal to 2 mmol/l.
Abbreviations
ED: Emergency department; IAI: Intra-abdominal infection; ICU: Intensive care
unit; SIRS: Systemic inflammatory response syndrome; SOFA: Sequential
[sepsis-related] Organ Failure Assessment
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